Exhibit 99.1 AVEANNA HEALTHCARE HOLDINGS ANNOUNCES FIRST QUARTER 2024 FINANCIAL RESULTS AND REVISED 2024 OUTLOOK • First Quarter Revenue was $490.7 million, a 5.2% increase over the prior year o Gross margin increased 1.0% to $145.9 million, compared to Q1 2023 • First Quarter Net loss was $11.2 million, compared to net loss of $32.0 million in the comparable prior year period o Adjusted EBITDA was $34.9 million, a 22.5% increase as compared to the prior year quarter • Full Year 2024 Revenue guidance raised ...

The upcoming report from Aveanna Healthcare (AVAH) is expected to reveal quarterly loss of $0.05 per share, indicating no change from the year-ago quarter compared to the year-ago period. Analysts forecast revenues of $485.05 million, representing an increase of 4% year over year.The consensus EPS estimate for the quarter has remained unchanged over the last 30 days. This reflects how the analysts covering the stock have collectively reevaluated their initial estimates during this timeframe.Before a company ...

ATLANTA, May 03, 2024 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. ("Aveanna") (NASDAQ:AVAH) today announced that its management team will attend the Barclays Leveraged Finance Conference in Austin, TX on May 21, 2024. Management will host 1x1 investor meetings that day. About Aveanna Healthcare Aveanna Healthcare is headquartered in Atlanta, Georgia and has locations in 33 states providing a broad range of pediatric and adult healthcare services including nursing, rehabilitation services, occupatio ...

ATLANTA, May 01, 2024 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. ("Aveanna") (NASDAQ:AVAH) today announced that its management team will attend the RBC Capital Markets Global Healthcare Conference in New York on May 14, 2024. Management will host 1x1 investor meetings as well as a fireside chat at 10:30 a.m. Eastern Time on the same day, May 14, 2024. Interested investors and other parties may also listen to a simultaneous webcast of the fireside chat by logging onto the Investor Relations section ...

ATLANTA, April 18, 2024 (GLOBE NEWSWIRE) --  Aveanna Healthcare Holdings Inc. ("Aveanna") (NASDAQ:AVAH) today announced that the company will release its first quarter results before the market open on Thursday, May 9, 2024, to be followed by a conference call at 10:00 a.m. (Eastern Time) on the same day. The conference call can be accessed live over the phone by dialing 1-877-407-0789 or for international callers, 1-201-689-8562. A replay will be available two hours after the call and can be accessed by di ...

ATLANTA, April 03, 2024 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH), a leading, diversified home care platform focused on providing care to medically complex, high-cost patient populations, today announced the appointment of Jerry Perchik to serve as Chief Legal Officer and Secretary, effective April 29, 2024. "I am pleased to announce the appointment of Jerry to the Chief Legal Officer and Secretary role. Jerry has a strong background in corporate law and a wealth of healthcare indus ...

财务数据和关键指标变化 - 第四季度收入约为4.79亿美元,同比增长6.1% [11] - 第四季度调整后EBITDA为3870万美元,同比增长30.4% [11] - 全年2023年收入和调整后EBITDA分别约为18.95亿美元和1.392亿美元,同比分别增长6%和7.6% [11] 各条业务线数据和关键指标变化 - 私人护理服务(PDS)业务第四季度收入约3.83亿美元,同比增长6.1%,提供护理时间约1010万小时,同比增长5.1% [39][40] - 家庭健康与临终关怀(Home Health & Hospice)业务第四季度收入约5400万美元,同比下降1.1%,入院量约9200例,其中约74%为按次付费 [43] - 医疗解决方案(Medical Solutions)业务第四季度收入4130万美元,同比增长17.5%,服务约9万名独特患者,同比增长8.4% [47] 各个市场数据和关键指标变化 - 在私人护理服务(PDS)业务中,公司在8个关键州获得了两位数的费率增长,另外11个州的费率增长也符合或略高于预期,这些州占PDS业务的约55% [17][18] - 在家庭健康与临终关怀(Home Health & Hospice)业务中,公司将按次付费比例从2022年末的约60%提高到2023年第四季度的74% [25] 公司战略和发展方向及行业竞争 - 公司将继续专注于四大战略:1)与政府和优选支付方合作以增加护理人员能力;2)识别成本效率和协同效应;3)管理资本结构并产生正现金流;4)吸引和激励员工 [29][30] - 公司认为行业不存在需求问题,政府和医疗保险机构都在寻求解决方案来增加服务能力 [13][28] - 公司通过与优选支付方合作,能够以更好的报酬率和价值型协议吸引和留住更多护理人员 [14][21][24] 管理层对经营环境和未来前景的评论 - 公司预计2024年全年收入将在19.6亿美元至19.8亿美元之间,调整后EBITDA将在1.46亿美元至1.5亿美元之间 [32] - 公司认为这一指引提供了谨慎的视角,考虑到了不断变化的劳动力市场的挑战 [32] - 公司对2024年的执行充满信心,将继续专注于与政府和优选支付方的合作,以及成本管理和现金流改善等关键战略 [29][30][57] 问答环节重要的提问和回答 问题1 **Taji Phillips 提问** 2024年的毛利率和EBITDA率预期是否合理,公司在哪些方面有机会超出预期? [60][61][62][63] **Jeff Shaner 和 Matt Buckhalter 回答** - 公司2024年的指引是谨慎的,与公司2023年的表现和行业趋势一致 [61][62] - 公司将继续专注于费率提升、成本管理和现金流改善等关键战略,这些都有助于EBITDA的增长 [61][62][63] - 如果公司在优选支付方合作和政府费率提升方面超出预期,都可能带来额外的上行空间 [62][63] 问题2 **Benjamin Hendrix 提问** 公司在加州的优选支付方策略进展如何,以及在其他未实现双位数费率增长的州,优选支付方渗透能否弥补差距? [69][70] **Jeff Shaner 回答** - 公司在加州持续推进政府事务和立法策略,同时也在加快优选支付方合作,预计未来18-24个月内会取得进展 [70] - 在其他未实现双位数费率增长的州,公司将加快优选支付方合作,这将有助于弥补差距 [70] 问题3 **Raj Kumar 提问** 在2024年,公司3大业务线中哪一个有最大的上升空间? [76][77][78][79] **Jeff Shaner 和 Matt Buckhalter 回答** - 3大业务线都有良好的增长潜力,但公司尤其看好家庭健康与临终关怀(Home Health & Hospice)业务的反弹 [77][78] - 该业务在过去1.5年里进行了整合和转型,现已回到良好的临床和财务表现,2024年有望继续保持强劲增长 [77][78][79] - 公司将继续专注于与优选支付方合作,提升该业务的盈利能力和现金流 [79]

Aveanna Healthcare (AVAH) reported $478.84 million in revenue for the quarter ended December 2023, representing a year-over-year increase of 6.1%. EPS of -$0.01 for the same period compares to -$0.03 a year ago.The reported revenue compares to the Zacks Consensus Estimate of $464.33 million, representing a surprise of +3.12%. The company delivered an EPS surprise of +50.00%, with the consensus EPS estimate being -$0.02.While investors closely watch year-over-year changes in headline numbers -- revenue and e ...

Aveanna Healthcare (AVAH) came out with a quarterly loss of $0.01 per share versus the Zacks Consensus Estimate of a loss of $0.02. This compares to loss of $0.03 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 50%. A quarter ago, it was expected that this home health care services provider would post a loss of $0.02 per share when it actually produced a loss of $0.03, delivering a surprise of -50%.Over the last four quarters, ...

财务表现 - 第四季度营收为4.788亿美元，较去年同期增长6.1%[1] - 毛利润增加15.3%，达到1.484亿美元[1] - 第四季度净亏损为2570万美元，较去年同期的2.378亿美元净亏损有所改善[1] - 调整后的EBITDA为3870万美元，较去年同期增长30.4%[1] - 预计2024年全年营收在19.6亿至19.8亿美元之间，调整后的EBITDA在1.46亿至1.5亿美元之间[1] 公司业绩 - 公司强调了2023年取得的实质性进展，包括营收和调整后的EBITDA分别较去年同期增长6.1%和30.4%[2] - 公司在2023年取得的强劲业绩证实了其转型业务的战略，强调扩大作为领先的价值为基础的家庭护理提供商的地位[2] 财务指标 - 毛利润为1.484亿美元，占营收的31.0%[3] - 第四季度净亏损为2570万美元，较去年同期的2.378亿美元净亏损有所改善[4] - 调整后的EBITDA为3870万美元，占营收的8.1%[5] 财务状况 - 公司截至2023年12月30日拥有4390万美元现金和2000万美元的额外借款能力[11] - 2023年迄今经营活动净现金流为2270万美元，自由现金流为1250万美元[12] - 公司截至2023年12月30日的银行债务为14.698亿美元，利率敞口通过利率互换和利率上限进行对冲[13]